Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline

Victor Chedid, Priya Vijayvargiya, Michael Camilleri

Research output: Contribution to journal › Article

2 Citations (Scopus)
Original languageEnglish (US)
JournalClinical Gastroenterology and Hepatology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

eluxadoline

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline. / Chedid, Victor; Vijayvargiya, Priya; Camilleri, Michael.

In: Clinical Gastroenterology and Hepatology, 01.01.2018.

Research output: Contribution to journal › Article

Chedid, V, Vijayvargiya, P & Camilleri, M 2018, 'Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline', Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2017.11.025
Chedid V, Vijayvargiya P, Camilleri M. Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline. Clinical Gastroenterology and Hepatology. 2018 Jan 1. https://doi.org/10.1016/j.cgh.2017.11.025
Chedid, Victor ; Vijayvargiya, Priya ; Camilleri, Michael. / Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline. In: Clinical Gastroenterology and Hepatology. 2018.
@article{1c1b2f0402fb442bb41c09f5cac0c62a,
title = "Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline",
author = "Victor Chedid and Priya Vijayvargiya and Michael Camilleri",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.cgh.2017.11.025",
language = "English (US)",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline

AU - Chedid, Victor

AU - Vijayvargiya, Priya

AU - Camilleri, Michael

PY - 2018/1/1

Y1 - 2018/1/1

UR - http://www.scopus.com/inward/record.url?scp=85040763184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040763184&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2017.11.025

DO - 10.1016/j.cgh.2017.11.025

M3 - Article

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

ER -

Access to Document